Philipp Henneke

Current position

W3 Professor of Infection and Immunity, Center for Pediatrics &
Institute for Immunodeficiency, Center for Chronic Immunodeficiency,
Medical Center – University of Freiburg

Academic training

1987 - 1994

Medical studies at Freie Universität, Berlin

Scientific qualifications

2005	Habilitation, Faculty of Medicine, University of Freiburg
1995	Dissertation in Medicine, Freie Universität Berlin

Postgraduate positions

since 2023	W3-Professor, Director, Institute for Infection Prevention and Hospital Hygiene
2012	W3 Professor Infection and Immunity, Head of Section for Pediatric Infectious Diseases and Rheumatology, CCI and Center for Pediatrics, Freiburg
2008 - 2012	Tenure Track Infection and Immunity and group leader, CCI Freiburg
2005 - 2012	Attending Physician (“Oberarzt”) in Pediatric Infectious Diseases and Immunology, Center of Pediatrics and Adolescent Medicine, Medical Center - University of Freiburg
2003 - 2009	Assistant Prof. (“Juniorprofessor”) in Pediatric Infectious Diseases, Medical Center - University of Freiburg
2001 - 2002	Lecturer, Harvard Medical School, USA
2001 - 2002	Instructor/ Assistant Prof. in Medicine, Univ. of Massachusetts, Worcester, USA
1999 - 2001	Postdoc at Division of Infectious Dis. and Immunology, Boston University, USA
1994 - 1999	Registrar in Pediatrics, Children’s Hospital, Freie Universität Berlin

Miscellaneous (Honors, Awards)

since 2023	CRC/TRR "PILOT", Speaker
since 2013	Coordinator Research Committee, ESPID
2009	Call W3-Professorship in Infection and Immunology, Tübingen Univ. (declined)
2008	Research Award, German Soc. of Pediatric Infectious Diseases
2007	Research Award, German Soc. of Neonatology and Pediatric Intensive Care
2003	Hugo-Schottmüller-Preis, German Sepsis Society
2003	Young Investigator Award, European Society of Pediatric Infectious Diseases

link to all publications from P. Henneke: Pubmed

Publications based on CRC1160 funding

Vinnakota JM, Biavasco F, Schwabenland M, Chhatbar C, Adams RC, Erny D, Duquesne S, El Khawanky N, Schmidt D, Fetsch V, Zähringer A, Salié H, Athanassopoulos D, Braun LM, Javorniczky NR, Ho JNHG, Kierdorf K, Marks R, Wäsch R, Simonetta F, Andrieux G, Pfeifer D, Monaco G, Capitini C, Fry TJ, Blank T, Blazar BR, Wagner E, Theobald M, Sommer C, Stelljes M, Reicherts C, Jeibmann A, Schittenhelm J, Monoranu CM, Rosenwald A, Kortüm M, Rasche L, Einsele H, Meyer PT, Brumberg J, Völkl S, Mackensen A, Coras R, von Bergwelt-Baildon M, Albert NL, Bartos LM, Brendel M, Holzgreve A, Mack M, Boerries M, Mackall CL, Duyster J, Henneke P, Priller J, Köhler N, Strübing F, Bengsch B, Ruella M, Subklewe M, von Baumgarten L, Gill S, Prinz M, Zeiser R. 2024. Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. Nat Cancer. May 13. doi: 10.1038/s43018-024-00764-7.